DGE	Genes	Process~name	num_of_Genes	gene_group	percentage%	P-value	Benjamini and Hochberg (FDR)	 Hommel singlewise process	Bonferroni single-step process	Hommel singlewise process	Hochberg step-up process	Benjamini and Yekutieli
down	LCE6A; LCE2B; KRT34; KRT75; KRT6B; KRT16; KRTAP2-3; KRT3; CASP14; KRT2; KRT76; DSG1; DSG2; KRT33B; LCE3E; LCE1C; LCE1D; LCE1E; LCE1F; LCE1B; LCE3A; LCE2A; LCE2C; LCE2D; KRT27; KRT77; KRTAP19-1; SPRR4; CNFN; KRTAP4-1; KRTAP3-1;	GO:0031424~keratinization	31	181	17.1270718232044	0	0	0	0	0	0	0
down	TGM5; KRT34; KRT75; CSTA; KRT6B; KRT16; KRT3; SPRR1B; SPRR2E; SPRR2D; TGM1; CASP14; SPRR2B; SPRR2A; KRT2; KRT76; DSG1; DSG2; KRT33B; LCE1A; LIPN; LIPM; SPINK6; KRT27; KRT77; LCE3D; SPRR2G; KLK5;	GO:0070268~cornification	28	113	24.7787610619469	0	0	0	0	0	0	0
down	GBX2; ISL1; ALX1; CORO1C; SEMA3A; SEMA3D; SEMA4A;	GO:0001755~neural crest cell migration	7	44	15.9090909090909	0.00011656637954549	0.00727152177164728	0.300624692847821	0.305403914409186	0.279409611770541	0.300624692847821	0.0614322598068941
down	LHX2; DLX2; SEMA3A; CRTAC1; NR2E1;	GO:0021772~olfactory bulb development	5	18	27.7777777777778	0.00011940906658813	0.00727562219676566	0.307836573664221	0.312851754460923	0.283715942213417	0.307836573664221	0.0614669015764028
up	UGT1A9; UGT2B11; UGT1A1; UGT1A3; UGT2B28; UGT1A7; UGT1A8; UGT1A10; UGT1A6;	GO:0052697~xenobiotic glucuronidation	9	9	100	0.00013201556409514	0.0289036429154194	0.489249680536607	0.491361929562129	0.489249680536607	0.489249680536607	0.254333745245941
down	CYP26A1; DKK1; RBP4; GJA1; NCOA1; TRIML2; RXRG;	GO:0032526~response to retinoic acid	7	46	15.2173913043478	0.00014943459153282	0.00889815067763649	0.385092942380094	0.391518629816006	0.328008928414554	0.385092942380094	0.0751745674971172
down	SULT2B1; IL1A; FTH1; REG1A; INHBA; AR; PTHLH; FOSL1; WT1; AZGP1; MSX1; SSTR5; CDKN1A; CDKN2B; TGFB2; GPLD1; FGFBP1; GPNMB; IFNL1; HIST1H2AC; BTG4; NUPR1;	GO:0008285~negative regulation of cell population proliferation	22	396	5.55555555555556	0.00016311928389833	0.00949716719585883	0.42019527532212	0.427372523813647	0.344868837627768	0.42019527532212	0.0802352603660487
down	NKX2-1; DLX1; DLX2; CDK5R2; NCOA1; FEZ1; LHX5; HSD3B1;	GO:0021766~hippocampus development	8	64	12.5	0.00017576014858611	0.00985672456017678	0.45258238260924	0.460491589295615	0.360308304601531	0.45258238260924	0.0832729218231578
down	UPK2; ENC1; LMX1B; IGF2; PIM1; EN2; HOXA11; HOXC12; TLX1; HOXD13; HMGA2; FOXL1; ALX1; TRIML1; HMX1; THEG; NKX1-2; EPHA8; FLT4; FST; MST1R; LTK; CDH10; SPINK6; ROS1; EPHA10;	GO:0007275~multicellular organism development	26	513	5.0682261208577	0.00017681910470546	0.00985672456017678	0.455132375511857	0.463266054328308	0.361432745148034	0.455132375511857	0.0832729218231578
down	HOXD9; MSX1; HOXA11; WNT3; EN1; ALX4;	GO:0035115~embryonic forelimb morphogenesis	6	33	18.1818181818182	0.00018867453215187	0.0102984848799567	0.485459571226782	0.49432727423792	0.374896295385781	0.485459571226782	0.0870050614755358
down	FGF2; FBXW7; NR2E1;	GO:0090049~regulation of cell migration involved in sprouting angiogenesis	3	3	100	0.00019769513968548	0.0105706380811422	0.508471899271063	0.517961265975966	0.385065587525074	0.508471899271063	0.0893043031869056
down	INHBA; MSX1; DLX5; DLX6; FOXF2; ALX1; VAX1; ALX4;	GO:0060021~roof of mouth development	8	66	12.1212121212121	0.00021299980851052	0.0111611899659517	0.547622507680567	0.558059498297583	0.402356638276387	0.547622507680567	0.0942934839878935
down	NUPR1; FOSL1; TGM1; FOXG1; TGFB2; NR2E1;	GO:0045787~positive regulation of cell cycle	6	35	17.1428571428571	0.00025055150642439	0.0126784789595695	0.643917371510683	0.656444946831902	0.443272325666753	0.643917371510683	0.107112051350439
down	KLK8; FST; KRT2; FERMT1;	GO:0043616~keratinocyte proliferation	4	11	36.3636363636364	0.00025473551086441	0.0126784789595695	0.654415527410675	0.66740703846476	0.447729243620885	0.654415527410675	0.107112051350439
down	UPK2; KRT3; WT1; AKR1C2; DLX5; DLX6; SIX1; ACTL8;	GO:0030855~epithelial cell differentiation	8	68	11.7647058823529	0.00025647304765541	0.0126784789595695	0.658622786379104	0.671959384857186	0.449597252539942	0.658622786379104	0.107112051350439
down	DKK1; INHBA; HOXC13; LHX2; TGFB2; ALX4;	GO:0001942~hair follicle development	6	37	16.2162162162162	0.00032734947307178	0.0158825114712605	0.840306097375261	0.857655619448066	0.505055369455492	0.840306097375261	0.134180794849964
down	EPCAM; GJA1; HMGA2; NR2E1;	GO:2000648~positive regulation of stem cell proliferation	4	12	33.3333333333333	0.00033378016183838	0.0159000731639375	0.856479895277288	0.87450402401656	0.509682307127209	0.856479895277288	0.134329161931994
down	PAX7; LHX1; LHX5; LHX3;	GO:0021527~spinal cord association neuron differentiation	4	13	30.7692307692308	0.00042894756536449	0.0200686182366958	1	1	0.566711983768076	0.996102557878926	0.169546431709683
down	GLI2; FST; MSX1; DLX1; DLX2; FOXC1; AMTN;	GO:0042475~odontogenesis of dentin-containing tooth	7	57	12.280701754386	0.00048933720404753	0.0224923416597288	1	1	0.598052228397835	0.996102557878926	0.19002286177476
down	DKK1; IL1A; PF4; REG1A; INHBA; AR; ALOX12; WT1; MT3; ID1; NKX2-1; HMGA2; WNT3; ACTC1; FOXD1; ARX; GATA5; RIMS2; IL1F10; IL36A;	GO:0010628~positive regulation of gene expression	20	374	5.3475935828877	0.00050012250894149	0.0225917409211501	1	1	0.60345456134135	0.996102557878926	0.190862620142267
down	KRT16; KRT2; FERMT1;	GO:0051546~keratinocyte migration	3	5	60	0.00053567350376448	0.0232789880035197	1	1	0.620845590863043	0.996102557878926	0.196668714470455
down	SEMA3A; SIX1; SIX4;	GO:0061551~trigeminal ganglion development	3	5	60	0.00053567350376448	0.0232789880035197	1	1	0.620845590863043	0.996102557878926	0.196668714470455
down	KCNK2; GJA1; CDKN1A; DNAJC2;	GO:2000279~negative regulation of DNA biosynthetic process	4	14	28.5714285714286	0.00054199170542546	0.0232789880035197	1	1	0.624025850006195	0.996102557878926	0.196668714470455
down	TRABD2B; KLK8; MMP1; ELANE; MMP10; DPEP1; ENDOU; CPS1; CASP14; MMP13; HTRA3; CTRB2; PRSS57; ADAMTS16; PYDC1; CASP10; PAPPA2; KLK9; KLK5; PLAU; CPA4; CPA2;	GO:0006508~proteolysis	22	436	5.04587155963303	0.00056658409579957	0.0239427472741109	1	1	0.636273939582919	0.996102557878926	0.202276375870739
down	GLI2; MSX1; NKX2-1; ISL1; LHX3;	GO:0021983~pituitary gland development	5	27	18.5185185185185	0.00060731550457204	0.025256613047282	1	1	0.655807379024586	0.996102557878926	0.2133763554986
down	NKX2-8; NUPR1; AR; CDKN2B; ISL1; TGFB2; TINF2;	GO:0050680~negative regulation of epithelial cell proliferation	7	60	11.6666666666667	0.00064741402059731	0.0265035114682026	1	1	0.674605409462402	0.996102557878926	0.223910572427644
down	NKX2-8; RBP4; GLI2; NKX2-1; WNT7B; FOXF1; FBXW7; LHX3;	GO:0030324~lung development	8	80	10	0.00069516691583881	0.0280205741461185	1	1	0.696872665261781	0.996102557878926	0.236727227799077
down	AR; HOXD9; HOXD10; HOXA11; FOXL2; MST1R; DEFB126;	GO:0007338~single fertilization	7	61	11.4754098360656	0.00070825815436348	0.0281157024913989	1	1	0.703091285736383	0.996102557878926	0.237530904031616
up	UGT1A9; UGT1A1; UGT1A3; UGT1A7; UGT1A8; UGT1A6; UGT1A10;	GO:0052696~flavonoid glucuronidation	7	7	100	0.00076587988870191	0.158366941430474	1	1	1	1	1
down	ID1; FOXF1; ERRFI1;	GO:0060426~lung vasculature development	3	6	50	0.00079045381821663	0.030069824137119	1	1	0.727993896482275	0.996102557878926	0.254039980453862
down	C1QL1; DKK1; EN1;	GO:0061743~motor learning	3	6	50	0.00079045381821663	0.030069824137119	1	1	0.727993896482275	0.996102557878926	0.254039980453862
down	ISL1; SIX1; DMRTA2; ISL2;	GO:0048665~neuron fate specification	4	16	25	0.00082883971111336	0.0310222863302429	1	1	0.737056904580548	0.996102557878926	0.262086701173641
down	GLI2; EN2; TGFB2; EN1; ISL2; WNK1;	GO:0048666~neuron development	6	47	12.7659574468085	0.00102466432370252	0.0378115567338112	1	1	0.781818878985021	0.996102557878926	0.319444739343522
down	GLI2; FST; HOXD12; LHX1; SIX1;	GO:0007389~pattern specification process	5	31	16.1290322580645	0.00105791917887055	0.0384965034533449	1	1	0.789295523380979	0.996102557878926	0.325231399433345
down	CTSV; MMP1; ELANE; MMP10; MMP13; CTRB2; KLK5;	GO:0022617~extracellular matrix disassembly	7	66	10.6060606060606	0.00108362969789888	0.0388919151848639	1	1	0.795384198257778	0.996102557878926	0.328571970634835
down	TGFB2; SIX1; SIX4;	GO:0048699~generation of neurons	3	7	42.8571428571429	0.00111089134402276	0.0393315583964814	1	1	0.801487298533605	0.996102557878926	0.332286224245919
down	LHX1; EN1; FOXC1; CDK5R2; NCOA1; GBX2;	GO:0021549~cerebellum development	6	48	12.5	0.00113168796994945	0.0395336330835673	1	1	0.806176195106285	0.996102557878926	0.333993419117543
down	RBP4; GJC1; GATA4; GATA5;	GO:0048738~cardiac muscle tissue development	4	18	22.2222222222222	0.00120870497423753	0.0416685135855569	1	1	0.823548031499689	0.996102557878926	0.352029607108656
up	UGT1A9; UGT2B17; UGT2B7; UGT1A6; UGT1A1; UGT1A4; UGT1A3; UGT1A7; UGT1A10;	GO:0052695~cellular glucuronidation	9	14	64.2857142857143	0.00122847524901015	0.240651835621884	1	1	1	1	1
down	NUPR1; INHBA; WT1; HOXA11; GATA4; TGFB2; NCOA1; SIX4;	GO:0008584~male gonad development	8	90	8.88888888888889	0.00140689845616404	0.0478710903266206	1	1	0.855394261347737	0.996102557878926	0.404431060036287
down	DLX2; DLX5; DLX1; DLX6;	GO:0009790~embryo development	4	19	21.0526315789474	0.00143803042844637	0.0483030733657626	1	1	0.859942196210928	0.996102557878926	0.408080597935798
down	HMGA2; ISL1; WWTR1;	GO:0048762~mesenchymal cell differentiation	3	8	37.5	0.00150271103493105	0.0486062087841894	1	1	0.869587565251811	0.996102557878926	0.410641587831212
down	MSX1; WNT3; WNT7B;	GO:0061180~mammary gland epithelium development	3	8	37.5	0.00150271103493105	0.0486062087841894	1	1	0.869587565251811	0.996102557878926	0.410641587831212
down	WT1; SIX1; SIX4;	GO:0072075~metanephric mesenchyme development	3	8	37.5	0.00150271103493105	0.0486062087841894	1	1	0.869587565251811	0.996102557878926	0.410641587831212
down	FLT4; FOXF1; STK40; ERRFI1; SLC7A11;	GO:0048286~lung alveolus development	5	34	14.7058823529412	0.00153088740531626	0.0489137195357147	1	1	0.873829837750482	0.996102557878926	0.413239542011143
down	CYP26A1; GLI2; WT1; LHX1; TGFB2; FOXC1; SIX1; HAS2;	GO:0001822~kidney development	8	94	8.51063829787234	0.0018171069388544	0.0547220710321669	1	1	0.91555193989549	0.996102557878926	0.462310447577445
up	UGT1A9; UGT1A1; UGT1A7; UGT1A10; UGT1A8; PPARGC1A;	GO:0051552~flavone metabolic process	6	6	100	0.0018673912013889	0.347521502578475	1	1	1	1	1
down	AR; DLX1; ISL1; DLX2; PA2G4;	GO:0045597~positive regulation of cell differentiation	5	36	13.8888888888889	0.00192233453483692	0.056513021542687	1	1	0.927529365456541	0.996102557878926	0.477440999409463
down	FGF2; WNT3; WNT7B;	GO:0072089~stem cell proliferation	3	9	33.3333333333333	0.00197116740858194	0.056513021542687	1	1	0.930315485708668	0.996102557878926	0.477440999409463
down	GJA1; GJC1; KCNQ1;	GO:0086014~atrial cardiac muscle cell action potential	3	9	33.3333333333333	0.00197116740858194	0.056513021542687	1	1	0.930315485708668	0.996102557878926	0.477440999409463
down	LMX1B; EN1; DMRTA2; FOXA2;	GO:0071542~dopaminergic neuron differentiation	4	21	19.047619047619	0.00198442671065924	0.056513021542687	1	1	0.930837921401071	0.996102557878926	0.477440999409463
down	FGF2; FGFBP1; FOXC2; PLK2;	GO:0090050~positive regulation of cell migration involved in sprouting angiogenesis	4	21	19.047619047619	0.00198442671065924	0.056513021542687	1	1	0.930837921401071	0.996102557878926	0.477440999409463
down	HOXC11; GLI2; HOXA11; HOXD12; HOXD13; ALX4;	GO:0042733~embryonic digit morphogenesis	6	55	10.9090909090909	0.00213892104601543	0.0602577757049508	1	1	0.939325805182844	0.996102557878926	0.509077941143742
down	HOXC11; HOXA11; SIX1;	GO:0001759~organ induction	3	10	30	0.00252106644786176	0.0667697458722676	1	1	0.958119250384888	0.996102557878926	0.564093253720152
down	REG1A; CPS1; FOXF1;	GO:0007494~midgut development	3	10	30	0.00252106644786176	0.0667697458722676	1	1	0.958119250384888	0.996102557878926	0.564093253720152
down	HOXD9; HOXD10; ISL2;	GO:0048935~peripheral nervous system neuron development	3	10	30	0.00252106644786176	0.0667697458722676	1	1	0.958119250384888	0.996102557878926	0.564093253720152
down	NKX2-1; PLA2G4E; TNFAIP8L3; PLA2G4F; PLA2G4D; PLPPR5;	GO:0006644~phospholipid metabolic process	6	57	10.5263157894737	0.00252297894708187	0.0667697458722676	1	1	0.958311596601869	0.996102557878926	0.564093253720152
down	KCNK2; SCEL; FOSL1; GATA4; BDKRB1; SOST;	GO:0009612~response to mechanical stimulus	6	57	10.5263157894737	0.00252297894708187	0.0667697458722676	1	1	0.958311596601869	0.996102557878926	0.564093253720152
down	MT2A; DPEP1; MT3; CERS1; KCNQ1; GPLD1;	GO:0035690~cellular response to drug	6	59	10.1694915254237	0.00295659547563909	0.0710667903318754	1	1	0.968844275529208	0.996102557878926	0.600396129505202
down	DPEP1; CHAC2; CHAC1;	GO:0006751~glutathione catabolic process	3	11	27.2727272727273	0.00315678668187691	0.0745115415001577	1	1	0.973146316269958	0.996102557878926	0.629498545118555
down	ELANE; TGFB2; IFNL1;	GO:0050778~positive regulation of immune response	3	11	27.2727272727273	0.00315678668187691	0.0745115415001577	1	1	0.973146316269958	0.996102557878926	0.629498545118555
down	CHP2; DPEP1; GPLD1; LCE1D; SYT3; SYT7; SYT8;	GO:0071277~cellular response to calcium ion	7	82	8.53658536585366	0.00339675911643189	0.0794599007593889	1	1	0.978336241232187	0.996102557878926	0.671303947230701
down	WNT3; SEMA3A; SEMA3D; SEMA4A;	GO:0048843~negative regulation of axon extension involved in axon guidance	4	25	16	0.00347719456543394	0.0798212393780821	1	1	0.980341348780094	0.996102557878926	0.674356657323433
down	KRT16; ALOX12; FLG2; GRHL1;	GO:0061436~establishment of skin barrier	4	25	16	0.00347719456543394	0.0798212393780821	1	1	0.980341348780094	0.996102557878926	0.674356657323433
down	ISL1; TGFB2; FOXC1; ALX1; WWTR1;	GO:0010718~positive regulation of epithelial to mesenchymal transition	5	42	11.9047619047619	0.00353407014040363	0.0798212393780821	1	1	0.981536357073155	0.996102557878926	0.674356657323433
down	FOSL1; TGFB2; DSG1; DSG2; NCOA1;	GO:0032570~response to progesterone	5	42	11.9047619047619	0.00353407014040363	0.0798212393780821	1	1	0.981536357073155	0.996102557878926	0.674356657323433
up	TRGV2; TRGV5; TRGV8; TRGV4; TRDV1; LILRA5; CD300LB; TYROBP; LY86; JCHAIN; C1QA; C1QB; C1QC; TRGV3; S100B; CFI; RNASE3; KLRC2; MATR3; CRISP3; LILRA4; SIGLEC14; NAIP; SLAMF1; PRKD1; CD300E; COLEC12; TRIL; TICAM2; CLEC10A; ZNF683; LILRA2; DEFB108B; DEFB104A; CLEC4C; RNASE6; PLD4; PGLYRP3; SIGLEC10; CD180; TRGV9; RARRES2; LGR4; CD209; TLR8; TLR7; IL36B; CD84; CLEC4A; TRDC; IGHV3-15; IGHV1OR15-9; IGHV3-66; IGHV4-61; IGHV3-48; IGHV2-70; IGHV1-69-2; IGHV2-26; IGHV4-59; IGHV3-23; IGHV4-39; TRBC1; IGHV3-53; IGHV1-3; TRBC2; IGHV4-4; IGHV3-30; IGLC3; IGHV3-13; IGHV3-49; IGLC7; IGHV1-2; IGHV3-21; IGHV6-1; IGHV5-51; IGHV3-7; IGHV3-33; IGHV3-72; IGHV1-18; IGHV1-46; IGHG4; IGHA2; IGLL5; IGHV1-45; IGLC2; IGHV3-74; IGHV1-24; IGHV3-73; IGHV4-31; IGHG3; IGHV3-11; IGHV1-69; IGHV4-34; IGKC; IGHV2-5; IGHD; IGHG2; IGHV3-43; IGHV3-20;	GO:0045087~innate immune response	99	505	19.6039603960396	0.00376789321072613	0.637459024105575	1	1	1	1	1
down	TALDO1; HK2; FBP2;	GO:0006002~fructose 6-phosphate metabolic process	3	12	25	0.00388229947463303	0.0847635385294879	1	1	0.988627840124551	0.996102557878926	0.716110861607933
down	MT2A; MT3; MT1X;	GO:0010038~response to metal ion	3	12	25	0.00388229947463303	0.0847635385294879	1	1	0.988627840124551	0.996102557878926	0.716110861607933
down	EMX2; ARX; LHX5;	GO:0021846~cell proliferation in forebrain	3	12	25	0.00388229947463303	0.0847635385294879	1	1	0.988627840124551	0.996102557878926	0.716110861607933
down	FGF2; FLRT3; MSX1;	GO:0048598~embryonic morphogenesis	3	12	25	0.00388229947463303	0.0847635385294879	1	1	0.988627840124551	0.996102557878926	0.716110861607933
up	CCR2; CXCR3; CCR5; CCR6; CCR8; GPR17; ACKR1; CCL26; CCL23; CCL2; CCL16; CCL21; CCL11; CCL13; CCL24; CCL14; TFF2; XCL2; CXCL13; CCL18; CCL19;	GO:0070098~chemokine-mediated signaling pathway	21	70	30	0.00404021967835411	0.653812940992782	1	1	1	1	1
down	GATA4; ISL1; TGFB2;	GO:0003215~cardiac right ventricle morphogenesis	3	13	23.0769230769231	0.00470118854681667	0.0886123308824437	1	1	0.996102557878926	0.996102557878926	0.748626752943291
down	AREG; TGM1; HAS2;	GO:0010838~positive regulation of keratinocyte proliferation	3	13	23.0769230769231	0.00470118854681667	0.0886123308824437	1	1	0.996102557878926	0.996102557878926	0.748626752943291
down	LHX1; DLX6; FLRT3;	GO:0060322~head development	3	13	23.0769230769231	0.00470118854681667	0.0886123308824437	1	1	0.996102557878926	0.996102557878926	0.748626752943291
down	GATA4; ISL1; TGFB2;	GO:0060413~atrial septum morphogenesis	3	13	23.0769230769231	0.00470118854681667	0.0886123308824437	1	1	0.996102557878926	0.996102557878926	0.748626752943291
down	ID1; WNT7B; STK40;	GO:0060425~lung morphogenesis	3	13	23.0769230769231	0.00470118854681667	0.0886123308824437	1	1	0.996102557878926	0.996102557878926	0.748626752943291
down	IL1A; FLT4; GATA4; ISL1;	GO:0010575~positive regulation of vascular endothelial growth factor production	4	28	14.2857142857143	0.00499957218130276	0.0910522744864542	1	1	0.996102557878926	0.996102557878926	0.769240216548693
down	GLI2; FST; TGFB2; KRT27;	GO:0031069~hair follicle morphogenesis	4	28	14.2857142857143	0.00499957218130276	0.0910522744864542	1	1	0.996102557878926	0.996102557878926	0.769240216548693
down	TCF15; FOXF1; FOXC1; FOXC2; HES7;	GO:0001756~somitogenesis	5	46	10.8695652173913	0.00503915259562437	0.0910522744864542	1	1	0.996102557878926	0.996102557878926	0.769240216548693
down	CXCL14; KCNQ1; TGFB2; SIX1; LHX3;	GO:0048839~inner ear development	5	46	10.8695652173913	0.00503915259562437	0.0910522744864542	1	1	0.996102557878926	0.996102557878926	0.769240216548693
down	MAP2K3; KCNQ1; ACTC1; TNNI2; TNNT1;	GO:0060048~cardiac muscle contraction	5	46	10.8695652173913	0.00503915259562437	0.0910522744864542	1	1	0.996102557878926	0.996102557878926	0.769240216548693
down	DKK1; DLX1; HTRA3; RBPMS2; SOST;	GO:0030514~negative regulation of BMP signaling pathway	5	47	10.6382978723404	0.00547676651938556	0.0968136325236167	1	1	0.996102557878926	0.996102557878926	0.817914105576921
down	IGF2; IL1A; FGF2; FGF5; TGFB2;	GO:0051781~positive regulation of cell division	5	47	10.6382978723404	0.00547676651938556	0.0968136325236167	1	1	0.996102557878926	0.996102557878926	0.817914105576921
down	RIMS2; SYT3; SYT7; SYT8;	GO:0017156~calcium-ion regulated exocytosis	4	29	13.7931034482759	0.00559220583785969	0.0968136325236167	1	1	0.996102557878926	0.996102557878926	0.817914105576921
down	FLT4; TCF15; STK40;	GO:0003016~respiratory system process	3	14	21.4285714285714	0.00561666875709532	0.0968136325236167	1	1	0.996102557878926	0.996102557878926	0.817914105576921
down	IGF2; MTPN; POPDC3;	GO:0051146~striated muscle cell differentiation	3	14	21.4285714285714	0.00561666875709532	0.0968136325236167	1	1	0.996102557878926	0.996102557878926	0.817914105576921
down	TGFB2; FOXC1; FOXC2;	GO:0060038~cardiac muscle cell proliferation	3	14	21.4285714285714	0.00561666875709532	0.0968136325236167	1	1	0.996102557878926	0.996102557878926	0.817914105576921
down	LTK; DLX5; FOXC1; IL18; DUX4L9; OGFOD1; USP13; SDCBP2; LIPG;	GO:0008283~cell population proliferation	9	142	6.33802816901408	0.0061560558145326	0.105108588820695	1	1	0.996102557878926	0.996102557878926	0.887992684219957
down	LHX2; TCF15; FOXC2; HES7;	GO:0007498~mesoderm development	4	30	13.3333333333333	0.00622990441513083	0.105108588820695	1	1	0.996102557878926	0.996102557878926	0.887992684219957
down	MSX1; MMP13; HAS2; PAPPA2;	GO:0060349~bone morphogenesis	4	30	13.3333333333333	0.00622990441513083	0.105108588820695	1	1	0.996102557878926	0.996102557878926	0.887992684219957
down	TGFB2; FOXC2; FERMT1;	GO:0033630~positive regulation of cell adhesion mediated by integrin	3	15	20	0.00663160416743613	0.105108588820695	1	1	0.996102557878926	0.996102557878926	0.887992684219957
down	PLA2G4D; PLA2G4F; PLA2G4E;	GO:0046475~glycerophospholipid catabolic process	3	15	20	0.00663160416743613	0.105108588820695	1	1	0.996102557878926	0.996102557878926	0.887992684219957
down	SERPINB5; SIX1; SIX4;	GO:0050678~regulation of epithelial cell proliferation	3	15	20	0.00663160416743613	0.105108588820695	1	1	0.996102557878926	0.996102557878926	0.887992684219957
down	KCNK2; RBP4; GJA1;	GO:0060044~negative regulation of cardiac muscle cell proliferation	3	15	20	0.00663160416743613	0.105108588820695	1	1	0.996102557878926	0.996102557878926	0.887992684219957
down	NUPR1; NQO1; SLC6A1; CDKN1A; SLC7A11; PON3;	GO:0009636~response to toxic substance	6	71	8.45070422535211	0.00681487910017131	0.105650788416857	1	1	0.996102557878926	0.996102557878926	0.892573368635771
down	HOXD9; HOXD10; SIX1; SIX4; POPDC3;	GO:0007519~skeletal muscle tissue development	5	50	10	0.00694964089750205	0.107106230302679	1	1	0.996102557878926	0.996102557878926	0.904869430845508
down	ITPRIP; PYDC1; TRIB3; CAMK2N2; WWTR1; WNK1;	GO:0006469~negative regulation of protein kinase activity	6	72	8.33333333333333	0.00724947102457074	0.111073766575294	1	1	0.996102557878926	0.996102557878926	0.938388510722702
down	CDC42EP2; MYO1B; CGNL1; FHOD3; PACSIN1; CORO1C; RHOD; ACTC1;	GO:0007015~actin filament organization	8	121	6.61157024793388	0.00758268940677842	0.113414170896735	1	1	0.996102557878926	0.996102557878926	0.958161033014871
down	SLC6A15; SLC6A1; SLC6A2; SLC6A11;	GO:0006810~transport	4	32	12.5	0.00764610257293419	0.113414170896735	1	1	0.996102557878926	0.996102557878926	0.958161033014871
down	FLT4; EPHA10; ROS1; EPHA8; LTK; MST1R;	GO:0033674~positive regulation of kinase activity	6	73	8.21917808219178	0.00770372335168523	0.113414170896735	1	1	0.996102557878926	0.996102557878926	0.958161033014871
down	PFN2; SEMA3A; CORO1C;	GO:0010633~negative regulation of epithelial cell migration	3	16	18.75	0.00774852541622728	0.113414170896735	1	1	0.996102557878926	0.996102557878926	0.958161033014871
down	INHBA; CDKN1A; CDKN2B;	GO:0042326~negative regulation of phosphorylation	3	16	18.75	0.00774852541622728	0.113414170896735	1	1	0.996102557878926	0.996102557878926	0.958161033014871
down	GLI2; TGFB2; FOXF2;	GO:0048566~embryonic digestive tract development	3	16	18.75	0.00774852541622728	0.113414170896735	1	1	0.996102557878926	0.996102557878926	0.958161033014871
down	CAMSAP2; KNDC1; CSMD3;	GO:0050773~regulation of dendrite development	3	16	18.75	0.00774852541622728	0.113414170896735	1	1	0.996102557878926	0.996102557878926	0.958161033014871
down	REG1A; FOXC1; WNK1;	GO:1990869~cellular response to chemokine	3	16	18.75	0.00774852541622728	0.113414170896735	1	1	0.996102557878926	0.996102557878926	0.958161033014871
down	CTSV; GRHL1; ERRFI1;	GO:0045616~regulation of keratinocyte differentiation	3	17	17.6470588235294	0.00896964642297249	0.128236167792912	1	1	0.996102557878926	0.996102557878926	1
down	FOSL1; CDKN1A; HSD3B1;	GO:0051412~response to corticosterone	3	17	17.6470588235294	0.00896964642297249	0.128236167792912	1	1	0.996102557878926	0.996102557878926	1
down	SNCG; SYT7; SYT8; SYT3;	GO:0014059~regulation of dopamine secretion	4	34	11.7647058823529	0.00925886087995842	0.128236167792912	1	1	0.996102557878926	0.996102557878926	1
down	NR2E1; WNT3; WNT7B; GATA5; GATA4;	GO:0045165~cell fate commitment	5	55	9.09090909090909	0.00998401288430495	0.132895698380327	1	1	0.996102557878926	0.996102557878926	1
down	RIMS4; POPDC3; RIMS2; GLRA4; GABRD; GABRA1; CHRNA9;	GO:0042391~regulation of membrane potential	7	102	6.86274509803922	0.0101306457409369	0.132895698380327	1	1	0.996102557878926	0.996102557878926	1
down	SLC6A15; SLC38A3; SLC7A5; SLC7A11;	GO:0003333~amino acid transmembrane transport	4	35	11.4285714285714	0.0101420578484929	0.132895698380327	1	1	0.996102557878926	0.996102557878926	1
down	NKX2-8; PTPRZ1; CTNNA2; SEMA4A; ISL2; ISL1;	GO:0007409~axonogenesis	6	78	7.69230769230769	0.0102864910175491	0.132895698380327	1	1	0.996102557878926	0.996102557878926	1
down	WNK1; NKAIN1; NKAIN4;	GO:0002028~regulation of sodium ion transport	3	18	16.6666666666667	0.0102968804470254	0.132895698380327	1	1	0.996102557878926	0.996102557878926	1
down	SYT8; SYT7; SYT3;	GO:0017158~regulation of calcium ion-dependent exocytosis	3	18	16.6666666666667	0.0102968804470254	0.132895698380327	1	1	0.996102557878926	0.996102557878926	1
down	GPAT3; LPIN2; DGAT2;	GO:0019432~triglyceride biosynthetic process	3	18	16.6666666666667	0.0102968804470254	0.132895698380327	1	1	0.996102557878926	0.996102557878926	1
down	GLI2; EN2; GBX2;	GO:0030902~hindbrain development	3	18	16.6666666666667	0.0102968804470254	0.132895698380327	1	1	0.996102557878926	0.996102557878926	1
down	FOSL1; CDKN1A; CDKN2B;	GO:0031668~cellular response to extracellular stimulus	3	18	16.6666666666667	0.0102968804470254	0.132895698380327	1	1	0.996102557878926	0.996102557878926	1
down	IFRD1; PAX7; MTPN;	GO:0043403~skeletal muscle tissue regeneration	3	18	16.6666666666667	0.0102968804470254	0.132895698380327	1	1	0.996102557878926	0.996102557878926	1
down	GRIK2; RIMS2; RIMS4;	GO:0050806~positive regulation of synaptic transmission	3	18	16.6666666666667	0.0102968804470254	0.132895698380327	1	1	0.996102557878926	0.996102557878926	1
down	ISL1; SIX1; SIX4;	GO:0060037~pharyngeal system development	3	18	16.6666666666667	0.0102968804470254	0.132895698380327	1	1	0.996102557878926	0.996102557878926	1
down	LHX1; SIX1; SIX4;	GO:0090190~positive regulation of branching involved in ureteric bud morphogenesis	3	18	16.6666666666667	0.0102968804470254	0.132895698380327	1	1	0.996102557878926	0.996102557878926	1
down	ZIC2; CRYAB; WT1; MT3; ID1; NKX2-1; LHX1; HMGA2; FOXG1; FOXL2; FOXF2; FOXD1; IFNL1; ESX1; DMBX1; TRIB3; HMX1; SIX4; PA2G4; SIX1; ALX1;	GO:0045892~negative regulation of transcription, DNA-templated	21	530	3.9622641509434	0.0107112325215987	0.136894776617505	1	1	0.996102557878926	0.996102557878926	1
down	FLRT3; SEMA3A; SEMA3D; SEMA4A;	GO:0050919~negative chemotaxis	4	36	11.1111111111111	0.0110780133253242	0.140895120933735	1	1	0.996102557878926	0.996102557878926	1
down	IL1A; FGF2; F3; GATA4; HK2; HMGA2; ISL1; NR2E1;	GO:0045766~positive regulation of angiogenesis	8	131	6.10687022900763	0.0116076203815588	0.142940510331549	1	1	0.996102557878926	0.996102557878926	1
down	PSAPL1; SPNS2; SERINC2;	GO:0006665~sphingolipid metabolic process	3	19	15.7894736842105	0.0117318555216629	0.142940510331549	1	1	0.996102557878926	0.996102557878926	1
down	PLA2G4E; PLA2G4F; PLA2G4D;	GO:0036149~phosphatidylinositol acyl-chain remodeling	3	19	15.7894736842105	0.0117318555216629	0.142940510331549	1	1	0.996102557878926	0.996102557878926	1
down	NPPB; FOXC1; FOXC2;	GO:0097746~regulation of blood vessel diameter	3	19	15.7894736842105	0.0117318555216629	0.142940510331549	1	1	0.996102557878926	0.996102557878926	1
down	PACSIN1; SYT8; ACTL8; ACTBL2;	GO:0048488~synaptic vesicle endocytosis	4	37	10.8108108108108	0.0120678164377743	0.142940510331549	1	1	0.996102557878926	0.996102557878926	1
down	GLI2; ADRA2C; FOXG1; NCOA1; GDF6; SH3GL3;	GO:0045666~positive regulation of neuron differentiation	6	81	7.40740740740741	0.0121020496070504	0.142940510331549	1	1	0.996102557878926	0.996102557878926	1
down	CRYAB; GJA1; MYL12A; GJC1; MYL7; TNNT1; TNNI2;	GO:0006936~muscle contraction	7	106	6.60377358490566	0.0121948685903533	0.142940510331549	1	1	0.996102557878926	0.996102557878926	1
down	TNNC2; TNNT1; TNNI2; ACTC1;	GO:0030049~muscle filament sliding	4	38	10.5263157894737	0.0131124988350327	0.152687764212381	1	1	0.996102557878926	0.996102557878926	1
down	HOXC11; GATA4; NKX2-1;	GO:0007492~endoderm development	3	20	15	0.0132759292856143	0.153228787349381	1	1	0.996102557878926	0.996102557878926	1
down	FGF5; EPCAM; MSX1;	GO:0023019~signal transduction involved in regulation of gene expression	3	20	15	0.0132759292856143	0.153228787349381	1	1	0.996102557878926	0.996102557878926	1
down	WT1; GJC1; FOXF1; HAS2; FBXW7;	GO:0001570~vasculogenesis	5	60	8.33333333333333	0.0138212358698621	0.158129423489252	1	1	0.996102557878926	0.996102557878926	1
down	ELANE; FGF2; MIF; MST1R; EPGN;	GO:0043406~positive regulation of MAP kinase activity	5	60	8.33333333333333	0.0138212358698621	0.158129423489252	1	1	0.996102557878926	0.996102557878926	1
down	IGF2; AR; ADRA2C; IL11; EPHA8; ADRA1B; FLT4;	GO:0043410~positive regulation of MAPK cascade	7	109	6.42201834862385	0.0139303284806706	0.158684611388508	1	1	0.996102557878926	0.996102557878926	1
down	DKK1; MT3; SEMA3A; ZNF365; RTN4RL1;	GO:0010977~negative regulation of neuron projection development	5	61	8.19672131147541	0.0146923882946056	0.159744707998311	1	1	0.996102557878926	0.996102557878926	1
down	FST; ID1; UBE2D1; DLX5; GDF6; TGFB2;	GO:0030509~BMP signaling pathway	6	85	7.05882352941176	0.0148580040743339	0.159744707998311	1	1	0.996102557878926	0.996102557878926	1
down	FOXC1; CYP26C1; FOXC2;	GO:0014032~neural crest cell development	3	21	14.2857142857143	0.0149302032318988	0.159744707998311	1	1	0.996102557878926	0.996102557878926	1
down	PLA2G4E; PLA2G4F; PLA2G4D;	GO:0036150~phosphatidylserine acyl-chain remodeling	3	21	14.2857142857143	0.0149302032318988	0.159744707998311	1	1	0.996102557878926	0.996102557878926	1
down	FBXW7; TRIB3; DCUN1D5;	GO:0051443~positive regulation of ubiquitin-protein transferase activity	3	21	14.2857142857143	0.0149302032318988	0.159744707998311	1	1	0.996102557878926	0.996102557878926	1
down	CPE; RAB38; PACSIN1;	GO:0072657~protein localization to membrane	3	21	14.2857142857143	0.0149302032318988	0.159744707998311	1	1	0.996102557878926	0.996102557878926	1
down	IGF2; FGF2; PAX3; LHX1; LHX3; LAMB4; LAMA3;	GO:0009887~animal organ morphogenesis	7	111	6.30630630630631	0.0151811010458844	0.159744707998311	1	1	0.996102557878926	0.996102557878926	1
down	HMGA2; TGFB2; FOXF2; AKNAD1;	GO:0001837~epithelial to mesenchymal transition	4	40	10	0.015370337955229	0.159744707998311	1	1	0.996102557878926	0.996102557878926	1
down	PF4; PGLYRP4; DEFB126; RNASE7; REG1A;	GO:0061844~antimicrobial humoral immune response mediated by antimicrobial peptide	5	62	8.06451612903226	0.0155995503235328	0.160277732735905	1	1	0.996102557878926	0.996102557878926	1
down	EMG1; NOL11; DDX21; LYAR; WDR3; PA2G4; ESF1; PIH1D2;	GO:0006364~rRNA processing	8	139	5.75539568345324	0.0158160072047691	0.161866948736308	1	1	0.996102557878926	0.996102557878926	1
down	CRYAB; MT3; HK2;	GO:2000378~negative regulation of reactive oxygen species metabolic process	3	22	13.6363636363636	0.0166955363939125	0.170203522770626	1	1	0.996102557878926	0.996102557878926	1
down	WT1; FOXC1; VAX1; FOXC2;	GO:0043010~camera-type eye development	4	42	9.52380952380952	0.0178586196919379	0.179270435221752	1	1	0.996102557878926	0.996102557878926	1
down	DLX1; DLX2; FBXW7; CHAC1;	GO:0045746~negative regulation of Notch signaling pathway	4	42	9.52380952380952	0.0178586196919379	0.179270435221752	1	1	0.996102557878926	0.996102557878926	1
down	PF4; NPPB; TGFB2; FOXC1; SEMA4A; PLK2;	GO:0016525~negative regulation of angiogenesis	6	89	6.74157303370786	0.0180216961391007	0.180216961391007	1	1	0.996102557878926	0.996102557878926	1
down	CXCL14; PLAU; REG1A; FGF2; CGB7; AR; AREG; GJA1; ENDOU; LTK; CAP2; GRIA2; MAP2K3; BCAM; GNGT1; MST1R; GRB14; FGFBP1; INSL4; GPNMB; ARTN; EPGN; ARHGAP27; CMTM8; CASKIN1; SH3GL3; DPYSL5; CORO1C; GABRD; CHRNA9; PLPPR5; GLRA4; GABRA1;	GO:0007165~signal transduction	33	989	3.33670374115268	0.0181454471438861	0.18076453048282	1	1	0.996102557878926	0.996102557878926	1
down	GLI2; HOXA11; DMBX1;	GO:0048589~developmental growth	3	23	13.0434782608696	0.0185725584883635	0.181786585306005	1	1	0.996102557878926	0.996102557878926	1
down	REG1A; SYT3; RIMS2;	GO:1903861~positive regulation of dendrite extension	3	23	13.0434782608696	0.0185725584883635	0.181786585306005	1	1	0.996102557878926	0.996102557878926	1
up	CD1A; CD1C; CD1E; CD1B;	GO:0048006~antigen processing and presentation, endogenous lipid antigen via MHC class Ib	4	5	80	0.0187504924563064	1	1	1	1	1	1
up	CCL24; HRH1; CCL11; CCL13; CCL18; CCL23; XCL2; CCL2;	GO:0048245~eosinophil chemotaxis	8	20	40	0.0191105424657217	1	1	1	1	1	1
up	TYROBP; CTLA4; IL10; FCGR2B; MNDA; CD300A; TNFRSF13B;	GO:0030889~negative regulation of B cell proliferation	7	16	43.75	0.0196565549087331	1	1	1	1	1	1
down	ME1; NCOA1; TNFAIP8L3; TRIB3; GRHL1; PSAPL1;	GO:0019216~regulation of lipid metabolic process	6	92	6.52173913043478	0.0206771569841319	0.195574553423919	1	1	0.996102557878926	0.996102557878926	1
up	UGT1A9; UGT1A1; CYP2C18; UGT1A3; UGT1A7; UGT1A8; ADH1B; ADH1C; ADH1A;	GO:0042573~retinoic acid metabolic process	9	25	36	0.0218868785668603	1	1	1	1	1	1
up	NR1I2; CYP2A6; CYP2C9; NOS1; CYP2C19; CYP2F1; CYP2C18; CYP2A7; CYP2G1P;	GO:0042738~exogenous drug catabolic process	9	25	36	0.0218868785668603	1	1	1	1	1	1
down	GLI2; FOXF1; IL18; PLA2G4F;	GO:0071407~cellular response to organic cyclic compound	4	45	8.88888888888889	0.0220363272309611	0.206251984295196	1	1	0.996102557878926	0.996102557878926	1
down	IL1A; IL36A; IL1F10;	GO:0002437~inflammatory response to antigenic stimulus	3	25	12	0.0226631169609662	0.206251984295196	1	1	0.996102557878926	0.996102557878926	1
down	CTSV; STC2; GJA1;	GO:0046697~decidualization	3	25	12	0.0226631169609662	0.206251984295196	1	1	0.996102557878926	0.996102557878926	1
down	ISL1; FOXC1; FOXC2;	GO:0055010~ventricular cardiac muscle tissue morphogenesis	3	25	12	0.0226631169609662	0.206251984295196	1	1	0.996102557878926	0.996102557878926	1
up	FMO1; CYP2F1; CYP2C19; CYP2A7; CYP2A6; CYP2C9; CYP2G1P; CYP2C18;	GO:0006082~organic acid metabolic process	8	21	38.0952380952381	0.0235499002566504	1	1	1	1	1	1
up	CYP2C9; CYP2C19; CYP4A11; CYP2G1P; CYP2A7; CYP2F1; CYP2C18; CYP2A6;	GO:0019373~epoxygenase P450 pathway	8	21	38.0952380952381	0.0235499002566504	1	1	1	1	1	1
up	APOA1; APOC3; APOA4; LPL; GPIHBP1;	GO:0034371~chylomicron remodeling	5	9	55.5555555555556	0.0237491013650276	1	1	1	1	1	1
down	TNNC2; TNNT1; TNNI2;	GO:0003009~skeletal muscle contraction	3	26	11.5384615384615	0.0248768772373662	0.209163891304844	1	1	0.996102557878926	0.996102557878926	1
down	PLA2G4E; PLA2G4F; PLA2G4D;	GO:0036152~phosphatidylethanolamine acyl-chain remodeling	3	26	11.5384615384615	0.0248768772373662	0.209163891304844	1	1	0.996102557878926	0.996102557878926	1
down	DSCAM; AR; MIF;	GO:0042327~positive regulation of phosphorylation	3	26	11.5384615384615	0.0248768772373662	0.209163891304844	1	1	0.996102557878926	0.996102557878926	1
down	KRT76; EN1; TYRP1;	GO:0043473~pigmentation	3	26	11.5384615384615	0.0248768772373662	0.209163891304844	1	1	0.996102557878926	0.996102557878926	1
down	STC2; AREG; GJA1; REG1A;	GO:0043434~response to peptide hormone	4	47	8.51063829787234	0.0251255992551067	0.209163891304844	1	1	0.996102557878926	0.996102557878926	1
down	GABRD; GABRA1; CLDN17; ANO4; SLC26A10; GLRA4;	GO:1902476~chloride transmembrane transport	6	97	6.18556701030928	0.0256699335673496	0.209163891304844	1	1	0.996102557878926	0.996102557878926	1
down	NUPR1; MT3; GATA4; DAPL1;	GO:0010507~negative regulation of autophagy	4	48	8.33333333333333	0.0267630019831131	0.209163891304844	1	1	0.996102557878926	0.996102557878926	1
down	INHBA; GDF6; TGFB2; INHBE;	GO:0010862~positive regulation of pathway-restricted SMAD protein phosphorylation	4	48	8.33333333333333	0.0267630019831131	0.209163891304844	1	1	0.996102557878926	0.996102557878926	1
down	MT1G; FLT4; MAP2K3;	GO:0035924~cellular response to vascular endothelial growth factor stimulus	3	27	11.1111111111111	0.0272027970154534	0.209163891304844	1	1	0.996102557878926	0.996102557878926	1
down	PLA2G4E; PLA2G4F; PLA2G4D;	GO:0036151~phosphatidylcholine acyl-chain remodeling	3	27	11.1111111111111	0.0272027970154534	0.209163891304844	1	1	0.996102557878926	0.996102557878926	1
down	EPHA8; LTK; FLT4; MATK; MAP2K3; MST1R; EPHA10;	GO:0018108~peptidyl-tyrosine phosphorylation	7	127	5.51181102362205	0.0281754696553156	0.209163891304844	1	1	0.996102557878926	0.996102557878926	1
up	APOA1; IL10; ANGPT1; LILRB1;	GO:0002740~negative regulation of cytokine secretion involved in immune response	4	6	66.6666666666667	0.0281792868827723	1	1	1	1	1	1
down	EPHA8; IL18; LAMA3; LMO7;	GO:0030155~regulation of cell adhesion	4	49	8.16326530612245	0.0284627958457907	0.209163891304844	1	1	0.996102557878926	0.996102557878926	1
down	MSX1; WNT3; ALX4;	GO:0035116~embryonic hindlimb morphogenesis	3	28	10.7142857142857	0.0296405388281638	0.209163891304844	1	1	0.996102557878926	0.996102557878926	1
down	INHBA; HMGA2; LAMA3;	GO:0035987~endodermal cell differentiation	3	28	10.7142857142857	0.0296405388281638	0.209163891304844	1	1	0.996102557878926	0.996102557878926	1
down	IGF2; IL1A; EPGN;	GO:0045840~positive regulation of mitotic nuclear division	3	28	10.7142857142857	0.0296405388281638	0.209163891304844	1	1	0.996102557878926	0.996102557878926	1
down	NUPR1; FTH1; C1QL4;	GO:0048147~negative regulation of fibroblast proliferation	3	28	10.7142857142857	0.0296405388281638	0.209163891304844	1	1	0.996102557878926	0.996102557878926	1
up	CCL21; IGF1; CCL19;	GO:0010560~positive regulation of glycoprotein biosynthetic process	3	3	100	0.0297476736990102	1	1	1	1	1	1
up	PAX6; NKX6-1; NKX6-2;	GO:0021912~regulation of transcription from RNA polymerase II promoter involved in spinal cord motor neuron fate specification	3	3	100	0.0297476736990102	1	1	1	1	1	1
up	NEFL; NEFM; NEFH;	GO:0033693~neurofilament bundle assembly	3	3	100	0.0297476736990102	1	1	1	1	1	1
up	MYO7B; ANKS4B; USH1C;	GO:1904970~brush border assembly	3	3	100	0.0297476736990102	1	1	1	1	1	1
up	LILRA5; LILRB1; TLR8;	GO:2001183~negative regulation of interleukin-12 secretion	3	3	100	0.0297476736990102	1	1	1	1	1	1
down	NR2E1; SIX1; SIX4; RXRG;	GO:0048856~anatomical structure development	4	50	8	0.0302253215100372	0.209163891304844	1	1	0.996102557878926	0.996102557878926	1
down	RSL1D1; SIX1; FBXW7; SIX4;	GO:0032880~regulation of protein localization	4	51	7.84313725490196	0.0320508650874101	0.209163891304844	1	1	0.996102557878926	0.996102557878926	1
down	HOXC11; HOXA11; FOXC2;	GO:0001656~metanephros development	3	29	10.3448275862069	0.032189604343391	0.209163891304844	1	1	0.996102557878926	0.996102557878926	1
down	MMP13; DLX5; FOXC1;	GO:0001958~endochondral ossification	3	29	10.3448275862069	0.032189604343391	0.209163891304844	1	1	0.996102557878926	0.996102557878926	1
down	EN2; MSX1; EN1;	GO:0030901~midbrain development	3	29	10.3448275862069	0.032189604343391	0.209163891304844	1	1	0.996102557878926	0.996102557878926	1
up	PTH; ADRA2A; NOS1; CAV3; LILRB2; LILRB1;	GO:0051926~negative regulation of calcium ion transport	6	14	42.8571428571429	0.0322286346878995	1	1	1	1	1	1
down	NKX2-8; AR; HOXD9; HOXC9; MLF1; NCOA1;	GO:0006351~transcription, DNA-templated	6	103	5.8252427184466	0.0326448667732966	0.209163891304844	1	1	0.996102557878926	0.996102557878926	1
down	CRYAB; AREG; NQO1; GJA1; SLC6A1; NCOA1;	GO:0032355~response to estradiol	6	103	5.8252427184466	0.0326448667732966	0.209163891304844	1	1	0.996102557878926	0.996102557878926	1
down	SLC5A12; SLC10A6; SLC38A3; SLC6A15; SLC5A1;	GO:0006814~sodium ion transport	5	77	6.49350649350649	0.033872655332345	0.209163891304844	1	1	0.996102557878926	0.996102557878926	1
down	NUPR1; NQO1; TGFB2; GRIK2;	GO:0043525~positive regulation of neuron apoptotic process	4	52	7.69230769230769	0.0339396589603342	0.209163891304844	1	1	0.996102557878926	0.996102557878926	1
down	GABRD; GABRA1; CHRNA9; GLRA4;	GO:0050877~nervous system process	4	52	7.69230769230769	0.0339396589603342	0.209163891304844	1	1	0.996102557878926	0.996102557878926	1
down	LHX1; LHX3; SEMA3A;	GO:0008045~motor neuron axon guidance	3	30	10	0.0348493441939616	0.209163891304844	1	1	0.996102557878926	0.996102557878926	1
down	SLCO1A2; NCOA1; SLC10A6;	GO:0015721~bile acid and bile salt transport	3	30	10	0.0348493441939616	0.209163891304844	1	1	0.996102557878926	0.996102557878926	1
down	GJA1; ADRA2C; ADRA1B;	GO:0045907~positive regulation of vasoconstriction	3	30	10	0.0348493441939616	0.209163891304844	1	1	0.996102557878926	0.996102557878926	1
down	KCNK2; MORN4; FLRT3;	GO:0048678~response to axon injury	3	30	10	0.0348493441939616	0.209163891304844	1	1	0.996102557878926	0.996102557878926	1
down	EPCAM; MSX1; HMGA2;	GO:0048863~stem cell differentiation	3	30	10	0.0348493441939616	0.209163891304844	1	1	0.996102557878926	0.996102557878926	1
down	RSL1D1; IGF2; DLX5; GPNMB; WWTR1; DDX21;	GO:0001649~osteoblast differentiation	6	106	5.66037735849057	0.0365514801257387	0.209163891304844	1	1	0.996102557878926	0.996102557878926	1
down	FGF19; FGF2; FGF5; FGFBP1; FLRT3;	GO:0008543~fibroblast growth factor receptor signaling pathway	5	79	6.32911392405063	0.0370112216593197	0.209163891304844	1	1	0.996102557878926	0.996102557878926	1
down	CPS1; HAAO; SLC30A3;	GO:0010043~response to zinc ion	3	31	9.67741935483871	0.0376189673983593	0.209163891304844	1	1	0.996102557878926	0.996102557878926	1
down	FGF2; EPHA8; TNFAIP8L3;	GO:0043552~positive regulation of phosphatidylinositol 3-kinase activity	3	31	9.67741935483871	0.0376189673983593	0.209163891304844	1	1	0.996102557878926	0.996102557878926	1
down	RBP4; PAX7; DLX1;	GO:0048706~embryonic skeletal system development	3	31	9.67741935483871	0.0376189673983593	0.209163891304844	1	1	0.996102557878926	0.996102557878926	1
down	DKK1; MSX1; DLX5;	GO:0060325~face morphogenesis	3	31	9.67741935483871	0.0376189673983593	0.209163891304844	1	1	0.996102557878926	0.996102557878926	1
down	PHGDH; PTHLH; LHX1; DUX4L9; STK40; ZNF485; YBX2; MAPK4;	GO:0010468~regulation of gene expression	8	166	4.81927710843374	0.0380494674052446	0.209163891304844	1	1	0.996102557878926	0.996102557878926	1
down	CPE; GLRA4; GAL; GPR1; NPPB; SSTR5;	GO:0007218~neuropeptide signaling pathway	6	108	5.55555555555556	0.0393151753698143	0.209163891304844	1	1	0.996102557878926	0.996102557878926	1
up	CYP2A6; UGT1A7; UGT1A8; CYP2A7;	GO:0009804~coumarin metabolic process	4	7	57.1428571428571	0.0399526540085885	1	1	1	1	1	1
up	POMC; SCT; SCTR; HTR4;	GO:0032098~regulation of appetite	4	7	57.1428571428571	0.0399526540085885	1	1	1	1	1	1
up	CD1C; CD1A; CD1B; CD1E;	GO:0048007~antigen processing and presentation, exogenous lipid antigen via MHC class Ib	4	7	57.1428571428571	0.0399526540085885	1	1	1	1	1	1
down	CDKN1A; CDKN2B; CDK5R2; CNPPD1;	GO:0000079~regulation of cyclin-dependent protein serine/threonine kinase activity	4	55	7.27272727272727	0.0399870790883168	0.209163891304844	1	1	0.996102557878926	0.996102557878926	1
up	MUC2; MUC6; MUC4; TFF3; TFF2; TFF1;	GO:0030277~maintenance of gastrointestinal epithelium	6	15	40	0.0404482141971958	1	1	1	1	1	1
up	SCT; ADCYAP1; ADCYAP1R1; SCTR; FFAR4; GPR62;	GO:0043950~positive regulation of cAMP-mediated signaling	6	15	40	0.0404482141971958	1	1	1	1	1	1
down	ADRA2C; MT3; IL18;	GO:0032148~activation of protein kinase B activity	3	32	9.375	0.040497550386061	0.209163891304844	1	1	0.996102557878926	0.996102557878926	1
down	FGF2; ID1; GPNMB;	GO:0045765~regulation of angiogenesis	3	32	9.375	0.040497550386061	0.209163891304844	1	1	0.996102557878926	0.996102557878926	1
down	DLX2; SIX1; SIX4;	GO:0048701~embryonic cranial skeleton morphogenesis	3	32	9.375	0.040497550386061	0.209163891304844	1	1	0.996102557878926	0.996102557878926	1
down	SEMA3A; SEMA3D; SEMA4A;	GO:0071526~semaphorin-plexin signaling pathway	3	32	9.375	0.040497550386061	0.209163891304844	1	1	0.996102557878926	0.996102557878926	1
down	GAL; MAFA; RIMS2;	GO:0030073~insulin secretion	3	33	9.09090909090909	0.0434840456417871	0.20942683746596	1	1	0.996102557878926	0.996102557878926	1
down	HOXD8; HOXC8; TCF15;	GO:0048705~skeletal system morphogenesis	3	33	9.09090909090909	0.0434840456417871	0.20942683746596	1	1	0.996102557878926	0.996102557878926	1
down	DLX1; DLX5; GATA5;	GO:0071773~cellular response to BMP stimulus	3	33	9.09090909090909	0.0434840456417871	0.20942683746596	1	1	0.996102557878926	0.996102557878926	1
up	TNFRSF13B; CXCL13; LILRA1; TRPA1; ADGRL2; F2; IFNG; IL2RA; CD3D; CD3G; SAG; CCL2; EDN3; NPR1; EDNRB; LAMA1; KLRC1; ADCYAP1R1; GLP1R; GCGR; SCTR; CXCR3; CCR5; ADGRE1; LILRB2; CLEC1A; GPHA2; ADGRE3; CLEC4A; TRBV24-1; TRBV19; TRBV6-6; TRBV5-1; CD80; TRBV6-1; TRBV27; TRBV3-1; TRBV2; TRBV28; TRBV7-2; TRBV4-1; TRBV7-6; TRBV29-1; TRBV30; TRBV20-1; TRBV6-5; TRBV12-4; TRBV5-4; TRBV9; TRBV18; TRBV7-9;	GO:0007166~cell surface receptor signaling pathway	51	268	19.0298507462687	0.0439291856336101	1	1	1	1	1	1
down	ELANE; ALOX12; IL18; RBPMS2;	GO:0048661~positive regulation of smooth muscle cell proliferation	4	57	7.01754385964912	0.0443368701744766	0.212752014390346	1	1	0.996102557878926	0.996102557878926	1
down	ID1; DLX5; DLX6; EPGN;	GO:0050679~positive regulation of epithelial cell proliferation	4	57	7.01754385964912	0.0443368701744766	0.212752014390346	1	1	0.996102557878926	0.996102557878926	1
down	AR; EN1; STK40; WWTR1; ETNK2;	GO:0035264~multicellular organism growth	5	84	5.95238095238095	0.0456156745840566	0.218488240238077	1	1	0.996102557878926	0.996102557878926	1
down	XPOT; SSB; NUP214;	GO:0006409~tRNA export from nucleus	3	34	8.82352941176471	0.0465772899817891	0.2199818582174	1	1	0.996102557878926	0.996102557878926	1
down	DKK1; KCNK2; MT3;	GO:0010942~positive regulation of cell death	3	34	8.82352941176471	0.0465772899817891	0.2199818582174	1	1	0.996102557878926	0.996102557878926	1
down	MSX1; GATA4; FOXD1;	GO:0030513~positive regulation of BMP signaling pathway	3	34	8.82352941176471	0.0465772899817891	0.2199818582174	1	1	0.996102557878926	0.996102557878926	1
down	MSX1; SIX1; SIX4;	GO:0034504~protein localization to nucleus	3	34	8.82352941176471	0.0465772899817891	0.2199818582174	1	1	0.996102557878926	0.996102557878926	1
up	PAX6; NKX6-1; NKX6-2;	GO:0021913~regulation of transcription from RNA polymerase II promoter involved in ventral spinal cord interneuron specification	3	4	75	0.0472459312268991	1	1	1	1	1	1
up	MESP1; ROBO2; ROBO1;	GO:0035481~positive regulation of Notch signaling pathway involved in heart induction	3	4	75	0.0472459312268991	1	1	1	1	1	1
up	CIDEA; APOA4; LY6D;	GO:0035634~response to stilbenoid	3	4	75	0.0472459312268991	1	1	1	1	1	1
down	FOXG1; ISL1; ISL2; NR2E1;	GO:0045665~negative regulation of neuron differentiation	4	59	6.77966101694915	0.0489408901204501	0.224154451305819	1	1	0.996102557878926	0.996102557878926	1
down	TGFB2; GDF6; INHBE; INHBA;	GO:0060395~SMAD protein signal transduction	4	59	6.77966101694915	0.0489408901204501	0.224154451305819	1	1	0.996102557878926	0.996102557878926	1
down	PTHLH; FOSL1; ADRA2C; ENDOU; SLC38A3;	GO:0007565~female pregnancy	5	86	5.81395348837209	0.0493635770723225	0.224154451305819	1	1	0.996102557878926	0.996102557878926	1
down	RBP4; TGFB2; FOXC1;	GO:0001654~eye development	3	35	8.57142857142857	0.0497760124762978	0.224154451305819	1	1	0.996102557878926	0.996102557878926	1
down	AREG; EPGN; ERRFI1;	GO:0042059~negative regulation of epidermal growth factor receptor signaling pathway	3	35	8.57142857142857	0.0497760124762978	0.224154451305819	1	1	0.996102557878926	0.996102557878926	1
down	GABRD; GRIA2; GABRA1;	GO:0060078~regulation of postsynaptic membrane potential	3	35	8.57142857142857	0.0497760124762978	0.224154451305819	1	1	0.996102557878926	0.996102557878926	1
down	FGF2; WT1; TGFB2;	GO:1902895~positive regulation of pri-miRNA transcription by RNA polymerase II	3	35	8.57142857142857	0.0497760124762978	0.224154451305819	1	1	0.996102557878926	0.996102557878926	1
